First-in-class medicine to prevent bleeding in haemophilia A patients with inhibitors

View source ↗

Summary

EMA announces a first-in-class medicine that prevents bleeding in patients with haemophilia A who have inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia